🎧 Subscribe to The Pulse by Wharton Digital Health on Apple, Spotify, Substack, or Twitter for more conversations with the leaders reshaping health tech.“Your muscle is your longevity organ.” — Dr. Rekha Kumar, Chief Medical Officer at FoundIn…
Continue Reading
What You Should Know:
– Philips announced the introduction of its VeriSight Pro 3D Intracardiac Echocardiography (ICE) catheter in Europe.
– Building on its successful adoption in the United States, VeriSight Pro provides physicians with real-time…
Continue Reading
Oregon Health & Science University Hospital is a 576-bed teaching hospital, biomedical research facility and Level I trauma center located on the campus of Oregon Health & Science University in Portland. It is at…
Continue Reading
Pulmonary vein isolation (PVI), the standard-of-care for atrial fibrillation (AF), is effective even in some persistent AF (PsAF) patients despite atrial fibrosis proliferation, suggesting that PVI could not only be isolating triggers but diminishing…
Continue Reading
Sub-Saharan Africa faces increasing heat events due to climate change, affecting health and productivity. Wearable technology, though promising for monitoring these impacts, is underexplored in this region. This pilot study evaluated the acceptability and…
Continue Reading
KardiaMobile 6L Max is powered by advanced AI to offer a wider range of arrhythmia detection.
What You Should Know:
– AliveCor, a leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced the launch of its…
Continue Reading
AI-driven heart scans which cut the need for invasive tests have saved millions of pounds, according to an analysis.
The Heartflow technology, which has been rolled out across 56 hospitals in England since 2021,…
FaceHeart from Taiwan has obtained regulatory approval in the United States for its AI-driven contactless technology for measuring respiratory rate. It obtained a 510(k) clearance from the US Food and Drug Administration for the respiratory…
Continue Reading
Despite significant advances, the prevention and management of cardiovascular disease remain challenging, especially for ischemic heart disease (IHD). Current clinical decision-making relies heavily on physician expertise, guideline-directed therapies, and static risk scores, which often…
Continue Reading
The integration of patient-reported outcomes (PROs) in digital health (DH) trials for cardiovascular diseases (CVDs) remains unknown. We searched ClinicalTrials.gov for randomized trials that tested DH interventions in CVDs from 2004 to 2024. The…
Continue Reading
